By Charles Blahous On March 12, President Biden signed the American Rescue Plan (ARP), a $1.9 trillion spending package moved through Congress on a party-line vote. The legislation is controversial for several reasons, one being that many of its provisions are wholly unrelated to the COVID pandemic from which it’s supposed to provide relief, […]
By Erik Sass, TES Editor-in-Chief As controversy continues to rage about the efficacy of hydroxychloroquine and other drugs against COVID-19, regulators and scientific authorities in the U.S. and abroad have consistently held up randomized controlled trials (RCTs) as the “gold standard” of drug efficacy research – but what if there was actually a way […]
The LA Times published a scathing (well, impassioned) editorial arguing that the EU’s new Copyright Directive could squash small companies that promote aspiring music and movie creators. To comply with the new law, everyone publishing content will need to employ sophisticated filtering technology that prevents such intolerable copyright abuses as parents sharing videos […]
